Depression in Functional Psychosis

  • D. G. C. Owens
  • Eve C. Johnstone


Despite a recent reappraisal of the concept of Unitary Psychosis (1), the Kraepelinian dichotomy of functional psychotic illnesses remains the theoretical and clinical orientation of most psychiatrists. The validity of this in defining separate disease entities is, of course, crucially based on outcome. Thus in establishing a diagnosis, Kraepelin urged consideration of...

“the entire picture... especially... the changes which it undergoes in the course of the disease” (2).

Such longitudinal methodology has, however, largely been abandoned in favour of the cross-sectional evaluation of symptomatology. Schneider, for example, stated that:

“Psychiatric diagnosis must be based on the presenting situation, not on the course taken by the illness” (3).


Major Depressive Episode Depressive Syndrome Abnormal Involuntary Movement Scale Fluphenazine Decanoate Depressive Feature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Crow TJ: The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 149: 419–429, 1986.Google Scholar
  2. 2.
    Kraepelin E: Dementia Praecox. Trans. R.M. Barclay. Robert E. Krieger. Huntington, New York, p. 257, 1971.Google Scholar
  3. 3.
    Schneider K: Clinical Psychopathology. Trans. M.W. Hamilton, Grune and Stratton, New York, London, p. 92, 1959.Google Scholar
  4. 4.
    Bleuler E: Dementia Praecox or the Group of Schizophrenias. Trans. Joseph Zinkin. International Universities Press, New York, p. 208, 1950.Google Scholar
  5. 5.
    Berrios GE, Bulbena A: Post psychotic depression: The Fulbourn cohort. Acta Psychiat Scand 76: 89–93, 1987.CrossRefGoogle Scholar
  6. 6.
    Falloon I, Watt DC, Shepherd M: A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med 8: 59–70, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Johnson DAW:. Studies of depressive symptoms in schizophrenia II: A two-year longitudinal study of symptoms. Br J Psychiatry 139: 93–96, 1981.Google Scholar
  8. 8.
    Glazer W, Prusoff B, John K et al: Depression and social adjustment among chronic schizophrenic outpatients. J Nery Ment Dis 169: 712–717, 1981.CrossRefGoogle Scholar
  9. 9.
    Roy A: Suicide in chronic schizophrenia. Br J Psychiatry 141: 171–177, 1982.CrossRefGoogle Scholar
  10. 10.
    Drake RE, Gates C, Cotton PG et al: Suicide among schizophrenics: Who is at risk? J Nery Ment Dis 172: 613–617, 1984.CrossRefGoogle Scholar
  11. 11.
    Johnstone EC, Crow TJ, Frith CD et al: The Northwick Park ‘functional’ psychosis study: Diagnosis and treatment response. Lancet ii: 119–125, 1988.Google Scholar
  12. 12.
    Wing JK, Cooper JE, Sartorius N: The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press. London, 1974.Google Scholar
  13. 13.
    Krawiecka M, Goldberg D, Vaughan M: A standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiat Scand 55: 299–308, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389, 1979.Google Scholar
  15. 15.
    Guy W: ECDEU Assessment Manual for Psychopharmacology. DHEW Washington DC, p. 534–537, 1976.Google Scholar
  16. 16.
    Wojcik JD, Gelenberg AJ, Labrie RA et al: Prevalence of tardive dyskinesia in an out-patient population. Compr Psychiatry 21: 370–380, 1980.Google Scholar
  17. 17.
    American Psychiatric Association: ’Diagnostic and Statistical Manual of Mental Disorders (Third Edition). APA, Washington DC, 1980.Google Scholar
  18. 18.
    Sonners AA: ‘Negative symptoms’: Conceptual and methodological problems. Schizophr Bull 11: 364–379, 1985.Google Scholar
  19. 19.
    Mayer M, Alpert M, Stastny P et al: Multiple contributions to clinical presentation of flat affect in schizophrenia. Schizophr Bull 11: 420–426, 1985.Google Scholar
  20. 20.
    Helmchen H, Hippius H: Depressive syndrome im verlauf neuroleptischer therapie. Nervenarzt 38: 455–458, 1967.Google Scholar
  21. 21.
    Roth S: The seemingly ubiquitous depression following acute schizophrenic episodes: a neglected area of clinical discussion. Am J Psychiatry 127: 91–98, 1970.Google Scholar
  22. 22.
    Shanfield S, Tucker GJ, Harrow M et al: The schizophrenic patient and depressive symptomatology. J Nery Ment Dis 151: 203–210, 1970.CrossRefGoogle Scholar
  23. 23.
    McGlashan TH, Carpenter WT Jr: Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 33: 231–239, 1976a.CrossRefGoogle Scholar
  24. McGlashan TH, Carpenter WT Jr: An investigation of the post-psychotic depressive syndrome. Am J Psychiatry 133: 14–19, 1976b.Google Scholar
  25. 25.
    Weissman MM, Pottenger M, Kleber H et al: Symptom patterns in primary and secondary depression. Arch Gen Psychiatry 34: 854–862, 1977.CrossRefGoogle Scholar
  26. 26.
    Cheadle AJ, Freeman HL, Korer, J: Chronic schizophrenic patients in the community. Br J Psychiatry 132: 221–227, 1978.Google Scholar
  27. 27.
    Knights A, Okasha MS, Salih MA et al: Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Br J Psychiatry 135: 515523, 1979.Google Scholar
  28. 28.
    Siris SG, Harmon GK, Endicott J: Postpsychotic depressive symptoms in hospitalised schizophrenic patients. Arch Gen Psychiatry 38: 1122–1123, 1981.PubMedCrossRefGoogle Scholar
  29. 29.
    Mandel MR, Severe JB, Schooler NR et al: Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 39: 197–203, 1982.Google Scholar
  30. 30.
    Guze SB, Cloninger R, Martin RL et al: A follow-up and family study of schizophrenia. Arch Gen Psychiatry 40: 1273–1276, 1983.CrossRefGoogle Scholar
  31. 31.
    Curson DA, Barnes TRE, Bamber RW et al: Long-term depot maintenance of chronic schizophrenic out-patients II: The incidence of compliance problems, side effects, neurotic symptoms and depression. Br J Psychiatry 146: 469–474, 1985.Google Scholar
  32. 32.
    Herz M: Prodromal symptoms and prevention of relapse in schizophrenia. J Clin Psychiatry 46: 22–25, 1985.Google Scholar
  33. 33.
    Planansky K, Johnston R: Depressive syndrome in schizophrenia. Acta Psychiat Scand 57: 207–218, 1978.CrossRefGoogle Scholar
  34. 34.
    Roy A: Depression in chronic paranoid schizophrenia. Br J Psychiatry 137: 138–139, 1980.PubMedCrossRefGoogle Scholar
  35. 35.
    Johnston DAW: Studies of depressive symptoms in schizophrenia I: The prevalence of depression and its possible causes. Br J Psychiatry 139: 89–93, 1981.Google Scholar
  36. 36.
    Strain F, Heger R, Klicpera C: The time structure of depressive mood in schizophrenic patients. Acta Psychiat Scand 65: 66–73, 1982.CrossRefGoogle Scholar
  37. 37.
    Moller HJ, von Zerssen D: Depression states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull 8: 109–117, 1982.Google Scholar
  38. 38.
    Lerner Y, Moscovich D: Depressive symptoms in acute schizophrenic hospitalised patients. J Clin Psychiatry 46: 483–484, 1985.Google Scholar
  39. 39.
    Martin RL, Cloninger R, Guze SB et al: Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 46: 9–13, 1985.Google Scholar
  40. 40.
    Drake RE, Cotton PG: Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry 148: 554–559, 1986.Google Scholar
  41. 41.
    Elk R, Dickman BJ, Teggin AF: Depression in schizophrenia: a study of prevalence and treatment. Br J Psychiatry 149: 228–229, 1986.PubMedCrossRefGoogle Scholar
  42. 42.
    Becker RE, Colliver JA, Verhulst SJ: Diagnosis of secondary depression in schizophrenia. J Clin Psychiatry 46: 4–8, 1985.Google Scholar
  43. 43.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (Third Edition-Revised). APA, Washington DC, 1987.Google Scholar
  44. 44.
    Prosser ES, Csernansky JG, Kaplan J et al: Depression, Parkinsonian symptoms and negative symptoms in schizophrenics treated with neuroleptics. J Nery Ment Dis 175: 100–105, 1987.CrossRefGoogle Scholar
  45. 45.
    De alarcon R, Carney MWP: Severe depressive mood changes following slow-release intramuscular fluphenazine injection. Br Med J 3: 564–567, 1969.Google Scholar
  46. 46.
    Floru, L, Heinrich K, Witter F: The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Int Pharmacopsychiatry 10: 230–239, 1975.PubMedGoogle Scholar
  47. 47.
    Knights A, Hirsch SR: ‘Revealed’ depression and drug treatment for schizophrenia. Arch Gen Psychiatry 38: 806–811, 1981.Google Scholar
  48. 48.
    Hirsch SR: Depression ‘revealed’ in schizophrenia. Br J Psychiatry 140: 421–424, 1982.CrossRefGoogle Scholar
  49. 49.
    Galdi J: The causality of depression in schizophrenia. Br J Psychiatry 142: 621–625, 1983.CrossRefGoogle Scholar
  50. 50.
    Van Putten T, May PRA: ‘Akinetic depression’ in schizophrenia. Arch Gen Psychiatry 35: 1101–1107, 1978.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • D. G. C. Owens
    • 1
  • Eve C. Johnstone
    • 1
  1. 1.Northwick Park Hospital and Clinical Research CentreHarrow, MiddlesexEngland

Personalised recommendations